See how a robotic-assisted innovation could help with knee-replacement surgery

Over three million people have knee-replacement surgery each year. The VELYS^TM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.

October 11, 2021

More from Johnson & Johnson

Innovation

May 20, 2026

The future of immunology

Learn about the advances Johnson & Johnson is making to potentially help treat the millions of people living with conditions in which the immune system mistakenly damages healthy cells in the body.

Health & wellness

May 19, 2026

Inflammation is the body’s natural response to injury or infection. But when it lingers, inflammation can lead to immune-mediated inflammatory diseases. Learn how Johnson & Johnson is innovating to help bring relief to those living with chronic inflammatory conditions.

Innovation

May 19, 2026

What is IL-23?

This pro-inflammatory protein is the target of potential Johnson & Johnson medications that could help treat immune-mediated diseases such as psoriasis, inflammatory bowel disease and rheumatoid arthritis.

Search Results

No Results

See how a robotic-assisted innovation could help with knee-replacement surgery

Over three million people have knee-replacement surgery each year. The VELYSTM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.

More from Johnson & Johnson

The future of immunology

What is inflammation?

What is IL-23?

Over three million people have knee-replacement surgery each year. The VELYS^TM Digital Surgery solution takes data unique to each patient’s anatomy to help a surgeon perform a more personalized knee replacement—which can help improve patient outcomes.